Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Pseudomonas aeruginosa , a Gram-negative bacterium, is one of the major pathogens implicated in human opportunistic infection and a common cause of clinically persistent infections such as cystic fibrosis, urinary tract infections, and burn infections. The main reason for the persistence of P. aeruginosa infections is due to the ability of P. aeruginosa to secrete extracellular polymeric substances such as exopolysaccharides, matrix proteins, and extracellular DNA during invasion. These substances adhere to and wrap around bacterial cells to form a biofilm. Biofilm formation leads to multiple antibiotic resistance in P. aeruginosa , posing a significant challenge to conventional single antibiotic therapeutic approaches. It has therefore become particularly important to develop anti-biofilm drugs. In recent years, a number of new alternative drugs have been developed to treat P. aeruginosa infectious biofilms, including antimicrobial peptides, quorum-sensing inhibitors, bacteriophage therapy, and antimicrobial photodynamic therapy. This article briefly introduces the process and regulation of P. aeruginosa biofilm formation and reviews several developed anti-biofilm treatment technologies to provide new directions for the treatment of P. aeruginosa biofilm infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics are commonly used to treat biofilm-related infections, but their effectiveness is limited by challenges such as drug resistance, restricted penetration through the biofilm matrix, and complex drug-microbe interactions [5, 6].”
From The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis (2025) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extracellular DNA Required for Bacterial Biofilm Formation
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C., & Mattick, J. S. (2002) · Science · doi:10.1126/science.295.5559.1487 · Cited by 2,203 · cited 1×
“When the biofilm matures to a certain extent, DNase treatment is no longer effective (Whitchurch et al., 2002).”
BackgroundBacteria and archaea on Earth and their abundance in biofilms
Flemming, H.-C., & Wuertz, S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0158-9 · Cited by 1,729 · cited 1×
“Most bacteria live in biofilms, which provide a protective niche for the survival of microorganisms (Kumar et al., 2017; Flemming and Wuertz, 2019).”
BackgroundStrategies for combating bacterial biofilm infections
Wu, H., Moser, C., Wang, H.-Z., Høiby, N., & Song, Z.-J. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2014.65 · Cited by 925
Antimicrobial photodynamic therapy – what we know and what we don’t
Cieplik, F., Deng, D., Crielaard, W., Buchalla, W., Hellwig, E., Al-Ahmad, A., & Maisch, T. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1467876 · Cited by 902
Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal
McDougald, D., Rice, S. A., Barraud, N., Steinberg, P. D., & Kjelleberg, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2695 · Cited by 881 · cited 1×
“NO has also been shown to regulate biofilms through targeted diffusion (McDougald et al., 2011), exerting an inhibitory effect in the final stages of biofilm formation.”
BackgroundIron and Pseudomonas aeruginosa biofilm formation
Banin, E., Vasil, M. L., & Greenberg, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504266102 · Cited by 801
Barken, K. B., Pamp, S. J., Yang, L., Gjermansen, M., Bertrand, J. J., Klausen, M., Givskov, M., Whitchurch, C. B., Engel, J. N., & Tolker‐Nielsen, T. (2008) · Environmental Microbiology · doi:10.1111/j.1462-2920.2008.01658.x · Cited by 418
Role of extracellular DNA in initial bacterial adhesion and surface aggregation
Das, T., Sharma, P. K., Busscher, H. J., van der Mei, H. C., & Krom, B. P. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.03119-09 · Cited by 326 · cited 1×
“As eDNA is essential for the initial attachment and aggregation of EPSs on the surface, this makes it difficult for bacteria to form an intact biofilm (Das et al., 2010; Srinivasan et al., 2021).”
BackgroundExtracellular DNA as a target for biofilm control
Okshevsky, M., Regina, V. R., & Meyer, R. L. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.12.002 · Cited by 299
Rendueles, O., Kaplan, J. B., & Ghigo, J. (2013) · Environmental Microbiology · doi:10.1111/j.1462-2920.2012.02810.x · Cited by 271 · cited 1×
“However, some bacterial exopolysaccharides can perform functions that inhibit or destabilize the biofilm (Rendueles et al., 2013).”
BackgroundBiofilms: Architecture, Resistance, Quorum Sensing and Control Mechanisms
Saxena, P., Joshi, Y., Rawat, K., & Bisht, R. (2019) · Indian Journal of Microbiology · doi:10.1007/s12088-018-0757-6 · Cited by 216
Nitric oxide regulation of bacterial biofilms
Arora, D. P., Hossain, S., Xu, Y., & Boon, E. M. (2015) · Biochemistry · doi:10.1021/bi501476n · Cited by 206
Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp. QY101
Jiang, P., Li, J., Han, F., Duan, G., Lu, X., Gu, Y., & Yu, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018514 · Cited by 165
DNase Inhibits Gardnerella vaginalis Biofilms In Vitro and In Vivo
Hymes, S. R., Randis, T. M., Sun, T. Y., & Ratner, A. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit047 · Cited by 96 · cited 2×
“This therapeutic enzyme disrupts biofilms through the hydrolysis of DNA in the extracellular matrix (Hymes et al., 2013).”
Background
Research works printed but not linked: 185
- Abdi, 2019, Bacterial resistance to antimicrobial peptides, J. Pept. Sci., 25, e3210, 10.1002/psc.3210 · DOI
- Abedon, 2021, Improving phage-biofilm in vitro experimentation, Viruses, 13, 1175, 10.3390/v13061175 · DOI
- Abedon, 2011, Phage treatment of human infections, Bacteriophage, 1, 66, 10.4161/bact.1.2.15845 · DOI · Paper page
- Ahmed, 2019, Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors, Appl. Microbiol. Biotechnol., 103, 3521, 10.1007/s00253-019-09618-0 · DOI · Paper page
- Al-Bakri, 2019, Photothermal-induced antibacterial activity of gold nanorods loaded into polymeric hydrogel against Pseudomonas aeruginosa biofilm, Molecules, 24, 2661, 10.3390/molecules24142661 · DOI
- Al-Dahmoshi, 2021, Pseudomonas aeruginosa: diseases, biofilm and antibiotic resistance
- Allesen-Holm, 2006, A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms, Mol. Microbiol., 59, 1114, 10.1111/j.1365-2958.2005.05008.x · DOI · Paper page
- Annunziato, 2020, Antimicrobial peptides (AMPs): A patent review (2015-2020), Expert Opin. Ther. Pat., 30, 931, 10.1080/13543776.2020.1851679 · DOI
- Martins Antunes de Melo, 2021, Antimicrobial photodynamic therapy (aPDT) for biofilm treatments. Possible synergy between aPDT and pulsed electric fields, Virulence, 12, 2247, 10.1080/21505594.2021.1960105 · DOI
- Aoki, 2013, Characterization of antimicrobial peptides toward the development of novel antibiotics, Pharmaceuticals (Basel), 6, 1055, 10.3390/ph6081055 · DOI · Paper page
- Azam, 2019, Updates on the pathogenicity status of Pseudomonas aeruginosa, Drug Discov. Today, 24, 350, 10.1016/j.drudis.2018.07.003 · DOI · Paper page
- Baker, 2016, Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms, Sci. Adv., 2, e1501632, 10.1126/sciadv.1501632 · DOI · Paper page
- Bala, 2015, Augmentation of virulence related traits of pqs mutants by pseudomonas quinolone signal through membrane vesicles, J. Basic Microbiol., 55, 566, 10.1002/jobm.201400377 · DOI
- Banin, 2008, The potential of desferrioxamine-gallium as an anti-pseudomonas therapeutic agent, Proc. Natl. Acad. Sci. U. S. A., 105, 16761, 10.1073/pnas.0808608105 · DOI · Paper page
- Barraud, 2006, Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa, J. Bacteriol., 188, 7344, 10.1128/JB.00779-06 · DOI · Paper page
- Barraud, 2012, Cephalosporin-3'-diazeniumdiolates: targeted NO-donor prodrugs for dispersing bacterial biofilms, Angew. Chem. Int. Ed. Engl., 51, 9057, 10.1002/anie.201202414 · DOI · Paper page
- Beaudoin, 2018, Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms, Sci. Rep., 8, 14728, 10.1038/s41598-018-33016-7 · DOI
- Beirao, 2014, Photodynamic inactivation of bacterial and yeast biofilms with a cationic porphyrin, Photochem. Photobiol., 90, 1387, 10.1111/php.12331 · DOI
- Bilici, 2020, Broad spectrum antibacterial photodynamic and photothermal therapy achieved with indocyanine green loaded SPIONs under near infrared irradiation, Biomater. Sci., 8, 4616, 10.1039/d0bm00821d · DOI
- Bonchi, 2015, Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum, Antimicrob. Agents Chemother., 59, 5641, 10.1128/AAC.01097-15 · DOI
- Byrd, 2009, Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production, Mol. Microbiol., 73, 622, 10.1111/j.1365-2958.2009.06795.x · DOI · Paper page
- Chanda, 2017, Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing, Exp. Ther. Med., 14, 4328, 10.3892/etm.2017.5110 · DOI
- Chang, 2019, Design, synthesis and evaluation of halogenated furanone derivatives as quorum sensing inhibitors in Pseudomonas aeruginosa, Eur. J. Pharm. Sci., 140, 105058, 10.1016/j.ejps.2019.105058 · DOI
- Chauhan, 2012, Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy, Antimicrob. Agents Chemother., 56, 6310, 10.1128/AAC.01606-12 · DOI
- Chegini, 2020, Bacteriophage therapy against Pseudomonas aeruginosa biofilms: A review, Ann. Clin. Microbiol. Antimicrob., 19, 45, 10.1186/s12941-020-00389-5 · DOI · Paper page
- Chou, 2019, Short, symmetric-helical peptides have narrow-spectrum activity with low resistance potential and high selectivity, Biomater. Sci., 7, 2394, 10.1039/c9bm00044e · DOI
- Chrzanowski, 2012, Why do microorganisms produce rhamnolipids?, World J. Microbiol. Biotechnol., 28, 401, 10.1007/s11274-011-0854-8 · DOI · Paper page
- Clokie, 2011, Phages in nature, Bacteriophage, 1, 31, 10.4161/bact.1.1.14942 · DOI · Paper page
- Colvin, 2013, PelA deacetylase activity is required for Pel polysaccharide synthesis in Pseudomonas aeruginosa, J. Bacteriol., 195, 2329, 10.1128/JB.02150-12 · DOI · Paper page
- Colvin, 2011, The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa, PLoS Pathog., 7, e1001264, 10.1371/journal.ppat.1001264 · DOI · Paper page
- Colvin, 2012, The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix, Environ. Microbiol., 14, 1913, 10.1111/j.1462-2920.2011.02657.x · DOI · Paper page
- Costerton, 1999, Bacterial biofilms: A common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
- Cutruzzola, 2016, Origin and impact of nitric oxide in Pseudomonas aeruginosa biofilms, J. Bacteriol., 198, 55, 10.1128/JB.00371-15 · DOI · Paper page
- Daboor, 2021, Disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate lyase enhances pathogen eradication by antibiotics, J. Cyst. Fibros., 20, 264, 10.1016/j.jcf.2020.04.006 · DOI
- Das, 2020, Pseudomonas aeruginosa biofilms and infections: roles of extracellular molecules,, 29, 10.1016/B978-0-444-64279-0.00003-7 · DOI
- Davey, 2003, Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1, J. Bacteriol., 185, 1027, 10.1128/JB.185.3.1027-1036.2003 · DOI · Paper page
- de la Fuente-Nunez, 2012, Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide, Antimicrob. Agents Chemother., 56, 2696, 10.1128/AAC.00064-12 · DOI · Paper page
- Di, 2020, Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria, Sci. Adv., 6, eaay6817, 10.1126/sciadv.aay6817 · DOI
- Donlan, 2002, Biofilms: microbial life on surfaces, Emerg. Infect. Dis., 8, 881, 10.3201/eid0809.020063 · DOI · Paper page
- Dosselli, 2012, Molecular targets of antimicrobial photodynamic therapy identified by a proteomic approach, J. Proteome, 77, 329, 10.1016/j.jprot.2012.09.007 · DOI
- Drenkard, 2003, Antimicrobial resistance of Pseudomonas aeruginosa biofilms, Microbes Infect., 5, 1213, 10.1016/j.micinf.2003.08.009 · DOI · Paper page
- Dufour, 2010, Bacterial biofilm: structure, function, and antimicrobial resistance, Endod. Top., 22, 2, 10.1111/j.1601-1546.2012.00277.x · DOI · Paper page
- Eckhart, 2007, DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus, Br. J. Dermatol., 156, 1342, 10.1111/j.1365-2133.2007.07886.x · DOI · Paper page
- Elmanama, 2020, Antimicrobial resistance and biofilm formation of Pseudomonas aeruginosa, Int. Arabic J. Antimicrob. Agents, 10, 3, 10.3823/846 · DOI
- Epstein, 2012, Liquid-infused structured surfaces with exceptional anti-biofouling performance, Proc. Natl. Acad. Sci. U. S. A., 109, 13182, 10.1073/pnas.1201973109 · DOI · Paper page
- Feng, 2021, Photodynamic and antibiotic therapy in combination against bacterial infections: efficacy, determinants, mechanisms, and future perspectives, Adv. Drug Deliv. Rev., 177, 113941, 10.1016/j.addr.2021.113941 · DOI · Paper page
- Feng, 2015, Functional synergy of alpha-helical antimicrobial peptides and traditional antibiotics against gram-negative and gram-positive bacteria in vitro and in vivo, Eur. J. Clin. Microbiol. Infect. Dis., 34, 197, 10.1007/s10096-014-2219-3 · DOI
- Ferriol-Gonzalez, 2020, Phages for biofilm removal, Antibiotics (Basel), 9, 268, 10.3390/antibiotics9050268 · DOI · Paper page
- Finkel, 2001, DNA as a nutrient: novel role for bacterial competence gene homologs, J. Bacteriol., 183, 6288, 10.1128/JB.183.21.6288-6293.2001 · DOI · Paper page
- Fleming, 2017, Glycoside hydrolases degrade polymicrobial bacterial biofilms in wounds, Antimicrob. Agents Chemother., 61, e01998-16, 10.1128/AAC.01998-16 · DOI · Paper page
- Franklin, 2011, Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl, Front. Microbiol., 2, 167, 10.3389/fmicb.2011.00167 · DOI · Paper page
- Ghafoor, 2011, Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture, Appl. Environ. Microbiol., 77, 5238, 10.1128/AEM.00637-11 · DOI · Paper page
- Ghorbani, 2017, In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa, GMS Hyg. Infect. Control., 12, Doc17, 10.3205/dgkh000302 · DOI
- Gnanadhas, 2015, Chronic lung infection by Pseudomonas aeruginosa biofilm is cured by L-methionine in combination with antibiotic therapy, Sci. Rep., 5, 16043, 10.1038/srep16043 · DOI
- Goss, 2018, Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections, Sci. Transl. Med., 10, eaat7520, 10.1126/scitranslmed.aat7520 · DOI · Paper page
- Harper, 2014, Bacteriophages and Biofilms, Antibiotics, 3, 270, 10.3390/antibiotics3030270 · DOI · Paper page
- Hoiby, 2010, Antibiotic resistance of bacterial biofilms, Int. J. Antimicrob. Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI · Paper page
- Hoiby, 2011, The clinical impact of bacterial biofilms, Int. J. Oral Sci., 3, 55, 10.4248/IJOS11026 · DOI · Paper page
- Hossain, 2017, Discovery of a novel nitric oxide binding protein and nitric-oxide-responsive signaling pathway in Pseudomonas aeruginosa, ACS Infect. Dis., 3, 454, 10.1021/acsinfecdis.7b00027 · DOI
- Howlin, 2017, Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis, Mol. Ther., 25, 2104, 10.1016/j.ymthe.2017.06.021 · DOI · Paper page
- Hu, 2018, Antimicrobial photodynamic therapy to control clinically relevant biofilm infections, Front. Microbiol., 9, 1299, 10.3389/fmicb.2018.01299 · DOI · Paper page
- Huang, 2019, An integrated genomic regulatory network of virulence-related transcriptional factors in Pseudomonas aeruginosa, Nat. Commun., 10, 2931, 10.1038/s41467-019-10778-w · DOI · Paper page
- Hughes, 2017, Novel approaches to the treatment of bacterial biofilm infections, Br. J. Pharmacol., 174, 2237, 10.1111/bph.13706 · DOI · Paper page
- Jamal, 2018, Bacterial biofilm and associated infections, J. Chin. Med. Assoc., 81, 7, 10.1016/j.jcma.2017.07.012 · DOI · Paper page
- Jennings, 2015, Pel is a cationic exopolysaccharide that cross-links extracellular DNA in the Pseudomonas aeruginosa biofilm matrix, Proc. Natl. Acad. Sci. U. S. A., 112, 11353, 10.1073/pnas.1503058112 · DOI · Paper page
- Jiang, 2020, Targeting biofilms therapy: current research strategies and development hurdles, Microorganisms, 8, 1222, 10.3390/microorganisms8081222 · DOI · Paper page
- Kalia, 2013, Quorum sensing inhibitors: An overview, Biotechnol. Adv., 31, 224, 10.1016/j.biotechadv.2012.10.004 · DOI · Paper page
- Kamal, 2017, Quorum sensing inhibitors as pathoblockers for Pseudomonas aeruginosa infections: A new concept in anti-infective drug discovery,, 185
- Kamaruzzaman, 2018, Targeting the bacterial protective armour; challenges and novel strategies in the treatment of microbial biofilm, Materials (Basel), 11, 1705, 10.3390/ma11091705 · DOI · Paper page
- Kaneko, 2007, The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity, J. Clin. Invest., 117, 877, 10.1172/JCI30783 · DOI · Paper page
- Kang, 2021, Pyoverdine inhibitors and gallium nitrate synergistically affect Pseudomonas aeruginosa, mSphere, 6, e0040121, 10.1128/mSphere.00401-21 · DOI
- Khan, 2020, Alternative strategies for the application of aminoglycoside antibiotics against the biofilm-forming human pathogenic bacteria, Appl. Microbiol. Biotechnol., 104, 1955, 10.1007/s00253-020-10360-1 · DOI
- Kim, 2016, Biofilm dispersion in Pseudomonas aeruginosa, J. Microbiol., 54, 71, 10.1007/s12275-016-5528-7 · DOI
- Kitao, 2018, Molecular insights into function and competitive inhibition of Pseudomonas aeruginosa multiple virulence factor regulator, mBio, 9, e02158-17, 10.1128/mBio.02158-17 · DOI
- Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies, Nat. Rev. Microbiol., 15, 740, 10.1038/nrmicro.2017.99 · DOI · Paper page
- Kostakioti, 2013, Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era, Cold Spring Harb. Perspect. Med., 3, a010306, 10.1101/cshperspect.a010306 · DOI · Paper page
- Kovach, 2020, Specific disruption of established Pseudomonas aeruginosa biofilms using polymer-attacking enzymes, Langmuir, 36, 1585, 10.1021/acs.langmuir.9b02188 · DOI
- Kumar, 2017, Biofilms: survival and defense strategy for pathogens, Int. J. Med. Microbiol., 307, 481, 10.1016/j.ijmm.2017.09.016 · DOI · Paper page
- Kumar, 2013, Zingerone inhibit biofilm formation and improve antibiofilm efficacy of ciprofloxacin against Pseudomonas aeruginosa PAO1, Fitoterapia, 90, 73, 10.1016/j.fitote.2013.06.017 · doi:10.1016/j.fitote.2013.06.017
- Kumar, 2015, Zingerone silences quorum sensing and attenuates virulence of Pseudomonas aeruginosa, Fitoterapia, 102, 84, 10.1016/j.fitote.2015.02.002 · DOI
- Kutateladze, 2010, Bacteriophages as potential new therapeutics to replace or supplement antibiotics, Trends Biotechnol., 28, 591, 10.1016/j.tibtech.2010.08.001 · DOI · Paper page
- Kutter, 2010, Phage therapy in clinical practice: treatment of human infections, Curr. Pharm. Biotechnol., 11, 69, 10.2174/138920110790725401 · DOI · Paper page
- Lashua, 2016, Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells, J. Antimicrob. Chemother., 71, 2200, 10.1093/jac/dkw143 · DOI
- Le, 2017, Intracellular targeting mechanisms by antimicrobial peptides, Antimicrob. Agents Chemother., 61, e02340-16, 10.1128/AAC.02340-16 · DOI · Paper page
- Lebeaux, 2015, In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections, J. Antimicrob. Chemother., 70, 1704, 10.1093/jac/dkv044 · DOI
- Lee, 2017, Pseudomonas aeruginosa biofilm, a programmed bacterial life for fitness, J. Microbiol. Biotechnol., 27, 1053, 10.4014/jmb.1611.11056 · DOI · Paper page
- Lee, 2015, The hierarchy quorum sensing network in Pseudomonas aeruginosa, Protein Cell, 6, 26, 10.1007/s13238-014-0100-x · DOI · Paper page
- Lequette, 2005, Timing and localization of rhamnolipid synthesis gene expression in Pseudomonas aeruginosa biofilms, J. Bacteriol., 187, 37, 10.1128/JB.187.1.37-44.2005 · DOI · Paper page
- Li, 2019, Near-infrared light-enhanced protease-conjugated gold nanorods as a photothermal antimicrobial agent for elimination of exotoxin and biofilms, Int. J. Nanomedicine, 14, 8047, 10.2147/IJN.S212750 · DOI
- Li, 2020, Mechanisms and control measures of mature biofilm resistance to antimicrobial agents in the clinical context, ACS Omega, 5, 22684, 10.1021/acsomega.0c02294 · DOI
- Liang, 2020, Effect of antibacterial photodynamic therapy on Streptococcus mutans plaque biofilm in vitro, J. Innov. Opt. Health Sci., 13, 2050022, 10.1142/S1793545820500224 · DOI
- Lichtenberg, 2022, The structure-function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment, FEMS Microbiol. Rev., 10.1093/femsre/fuac018 · DOI · Paper page
- Limoli, 2015, Bacterial extracellular polysaccharides in biofilm formation and function, Microbiol. Spectr., 3, MB-0011, 10.1128/microbiolspec.MB-0011-2014 · DOI · Paper page
- Limoli, 2014, Cationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infections, PLoS Pathog., 10, e1004083, 10.1371/journal.ppat.1004083 · DOI · Paper page
- Lin, 2019, Quorum sensing in Pseudomonas aeruginosa and its relationship to biofilm development,, 1, 10.1021/bk-2019-1323.ch001 · DOI
- Lin, The pseudomonas quinolone signal (PQS): not just for quorum sensing anymore, Front. Cell. Infect. Microbiol., 8, 230, 10.3389/fcimb.2018.00230 · DOI · Paper page
- Lin, Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37, Int. J. Antimicrob. Agents, 52, 667, 10.1016/j.ijantimicag.2018.04.019 · DOI
- Lin, 2021, Acidic microenvironment determines antibiotic susceptibility and biofilm formation of Pseudomonas aeruginosa, Front. Microbiol., 12, 747834, 10.3389/fmicb.2021.747834 · DOI
- Llamas, 2006, The heterologous siderophores ferrioxamine B and ferrichrome activate signaling pathways in Pseudomonas aeruginosa, J. Bacteriol., 188, 1882, 10.1128/JB.188.5.1882-1891.2006 · DOI · Paper page
- Ma, 2009, Assembly and development of the Pseudomonas aeruginosa biofilm matrix, PLoS Pathog., 5, e1000354, 10.1371/journal.ppat.1000354 · DOI · Paper page
- Ma, 2006, Analysis of Pseudomonas aeruginosa conditional Psl variants reveals roles for the Psl polysaccharide in adhesion and maintaining biofilm structure postattachment, J. Bacteriol., 188, 8213, 10.1128/JB.01202-06 · DOI · Paper page
- Ma, 2022, Regulation of biofilm exopolysaccharide biosynthesis and degradation in Pseudomonas aeruginosa, Annu. Rev. Microbiol., 76, 413, 10.1146/annurev-micro-041320-111355 · DOI
- Ma, 2012, The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms, FEMS Immunol. Med. Microbiol., 65, 377, 10.1111/j.1574-695X.2012.00934.x · DOI · Paper page
- Mahlapuu, 2016, Antimicrobial peptides: An emerging category of therapeutic agents, Front. Cell. Infect. Microbiol., 6, 194, 10.3389/fcimb.2016.00194 · DOI · Paper page
- Mann, 2012, Pseudomonas biofilm matrix composition and niche biology, FEMS Microbiol. Rev., 36, 893, 10.1111/j.1574-6976.2011.00322.x · DOI · Paper page
- Marmont, 2017, PelA and PelB proteins form a modification and secretion complex essential for Pel polysaccharide-dependent biofilm formation in Pseudomonas aeruginosa, J. Biol. Chem., 292, 19411, 10.1074/jbc.M117.812842 · DOI
- Marshall, 2009, Citrate-mediated iron uptake in Pseudomonas aeruginosa: involvement of the citrate-inducible FecA receptor and the FeoB ferrous iron transporter, Microbiology (Reading), 155, 305, 10.1099/mic.0.023531-0 · DOI · Paper page
- Martinez, 2019, Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa, Biochim. Biophys. Acta Biomembr., 1861, 1329, 10.1016/j.bbamem.2019.05.008 · DOI
- Maura, 2017, Pharmacological inhibition of the Pseudomonas aeruginosa MvfR quorum-sensing system interferes with biofilm formation and potentiates antibiotic-mediated biofilm disruption, Antimicrob. Agents Chemother., 61, e01362-17, 10.1128/AAC.01362-17 · DOI
- Maurice, 2018, Pseudomonas aeruginosa biofilms: Host response and clinical implications in lung infections, Am. J. Respir. Cell Mol. Biol., 58, 428, 10.1165/rcmb.2017-0321TR · DOI · Paper page
- Melo, 2019, Phage therapy of infectious biofilms: challenges and strategies,, 295, 10.1007/978-3-030-26736-0_11 · DOI
- Mi, 2019, Identification of a lytic Pseudomonas aeruginosa phage depolymerase and its anti-biofilm effect and bactericidal contribution to serum, Virus Genes, 55, 394, 10.1007/s11262-019-01660-4 · DOI
- Minandri, 2014, Promises and failures of gallium as an antibacterial agent, Future Microbiol., 9, 379, 10.2217/fmb.14.3 · DOI
- Mitchell, 2016, Fungal super glue: the biofilm matrix and its composition, assembly, and functions, PLoS Pathog., 12, e1005828, 10.1371/journal.ppat.1005828 · DOI · Paper page
- Moradali, 2017, Pseudomonas aeruginosa lifestyle: A paradigm for adaptation, survival, and persistence, Front. Cell. Infect. Microbiol., 7, 39, 10.3389/fcimb.2017.00039 · DOI · Paper page
- Moradali, 2019, The role of alginate in bacterial biofilm formation,, 517, 10.1007/978-3-030-12919-4_13 · DOI
- Muhlen, 2016, Anti-virulence strategies to target bacterial infections, Curr. Top. Microbiol. Immunol., 398, 147, 10.1007/82_2015_490 · DOI · Paper page
- O'Brien, 2015, Potent irreversible inhibitors of LasR quorum sensing in Pseudomonas aeruginosa, ACS Med. Chem. Lett., 6, 162, 10.1021/ml500459f · DOI
- Olivares, 2019, Clinical impact of antibiotics for the treatment of Pseudomonas aeruginosa biofilm infections, Front. Microbiol., 10, 2894, 10.3389/fmicb.2019.02894 · DOI · Paper page
- Overhage, 2008, Human host defense peptide LL-37 prevents bacterial biofilm formation, Infect. Immun., 76, 4176, 10.1128/IAI.00318-08 · DOI · Paper page
- Pang, 2019, Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies, Biotechnol. Adv., 37, 177, 10.1016/j.biotechadv.2018.11.013 · DOI · Paper page
- Pang, 2021, Traditional Chinese medicine is an alternative therapeutic option for treatment of Pseudomonas aeruginosa infections, Front. Pharmacol., 12, 737252, 10.3389/fphar.2021.737252 · DOI
- Pei, 2014, Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes, Appl. Environ. Microbiol., 80, 5340, 10.1128/AEM.01434-14 · DOI · Paper page
- Perez-Laguna, 2020, Photodynamic therapy using methylene blue, combined or not with gentamicin, against Staphylococcus aureus and Pseudomonas aeruginosa, Photodiagn. Photodyn. Ther., 31, 101810, 10.1016/j.pdpdt.2020.101810 · DOI
- Pires, 2016, Bacteriophage-encoded depolymerases: their diversity and biotechnological applications, Appl. Microbiol. Biotechnol., 100, 2141, 10.1007/s00253-015-7247-0 · DOI · Paper page
- Poh, 2022, Recent developments in nitric oxide donors and delivery for antimicrobial and anti-biofilm applications, Molecules, 27, 674, 10.3390/molecules27030674 · DOI · Paper page
- Pontes, 2022, Antimicrobial peptides as an alternative for the eradication of bacterial biofilms of multi-drug resistant bacteria, Pharmaceutics, 14, 642, 10.3390/pharmaceutics14030642 · DOI
- Qi, 2019, Role of flagella, type IV Pili, biosurfactants, and extracellular polymeric substance polysaccharides on the formation of pellicles by Pseudomonas aeruginosa, Langmuir, 35, 5294, 10.1021/acs.langmuir.9b00271 · DOI
- Qin, 2009, Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis, Microbiology (Reading), 155, 2148, 10.1099/mic.0.028001-0 · DOI · Paper page
- Rahmani-Badi, 2014, A combination of cis-2-decenoic acid and antibiotics eradicates pre-established catheter-associated biofilms, J. Med. Microbiol., 63, 1509, 10.1099/jmm.0.075374-0 · DOI
- Rajesh, 2011, Antimicrobial photodynamic therapy: An overview, J. Indian Soc. Periodontol., 15, 323, 10.4103/0972-124X.92563 · DOI
- Rajkumari, 2018, Cinnamic acid attenuates quorum sensing associated virulence factors and biofilm formation in Pseudomonas aeruginosa PAO1, Biotechnol. Lett., 40, 1087, 10.1007/s10529-018-2557-9 · DOI
- Redman, 2020, Differential efficacy of glycoside hydrolases to disperse biofilms, Front. Cell. Infect. Microbiol., 10, 379, 10.3389/fcimb.2020.00379 · DOI
- Roy, 2018, Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action, Virulence, 9, 522, 10.1080/21505594.2017.1313372 · DOI · Paper page
- Rumbaugh, 2020, Biofilm dispersion, Nat. Rev. Microbiol., 18, 571, 10.1038/s41579-020-0385-0 · DOI · Paper page
- Rutherford, 2012, Bacterial quorum sensing: its role in virulence and possibilities for its control, Cold Spring Harb. Perspect. Med., 2, a012427, 10.1101/cshperspect.a012427 · DOI · Paper page
- Rzhepishevska, 2011, The antibacterial activity of Ga3+ is influenced by ligand complexation as well as the bacterial carbon source, Antimicrob. Agents Chemother., 55, 5568, 10.1128/AAC.00386-11 · DOI
- Schmelcher, 2012, Bacteriophage endolysins as novel antimicrobials, Future Microbiol., 7, 1147, 10.2217/fmb.12.97 · DOI · Paper page
- Schutz, 2018, Targeting the pseudomonas quinolone signal quorum sensing system for the discovery of novel anti-infective pathoblockers, Beilstein J. Org. Chem., 14, 2627, 10.3762/bjoc.14.241 · DOI
- Schutz, 2021, A new PqsR inverse agonist potentiates tobramycin efficacy to eradicate Pseudomonas aeruginosa biofilms, Adv. Sci. (Weinh), 8, e2004369, 10.1002/advs.202004369 · DOI
- Seyfi, 2020, Antimicrobial peptides (AMPs): roles, functions and mechanism of action, Int. J. Pept. Res. Ther., 26, 1451, 10.1007/s10989-019-09946-9 · DOI · Paper page
- Shao, 2020, Novel therapeutic strategies for treating Pseudomonas aeruginosa infection, Expert Opin. Drug Discov., 15, 1403, 10.1080/17460441.2020.1803274 · DOI
- Sharma, 2019, Antibiotics versus biofilm: An emerging battleground in microbial communities, Antimicrob. Resist. Infect. Control, 8, 76, 10.1186/s13756-019-0533-3 · DOI · Paper page
- Sharma, 2018, Antibiofilm effect of DNase against single and mixed species biofilm, Foods, 7, 42, 10.3390/foods7030042 · DOI
- Shrestha, 2022, Recent strategies to combat biofilms using antimicrobial agents and therapeutic approaches, Pathogens, 11, 292, 10.3390/pathogens11030292 · DOI
- Shrivastava, 2018, World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, J. Med. Soc., 32, 76, 10.4103/jms.jms_25_17 · DOI · Paper page
- Smith, 2017, Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis, FEMS Microbiol. Lett., 364, fnx121, 10.1093/femsle/fnx121 · DOI
- Soothill, 2013, Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections, Expert Rev. Anti Infect. Ther., 11, 909, 10.1586/14787210.2013.826990 · DOI
- Soren, 2020, Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa, J. Antimicrob. Chemother., 75, 117, 10.1093/jac/dkz378 · DOI
- Soukarieh, 2018, Pseudomonas aeruginosa quorum sensing systems as drug discovery targets: current position and future perspectives, J. Med. Chem., 61, 10385, 10.1021/acs.jmedchem.8b00540 · DOI
- Srinivasan, 2021, Bacterial biofilm inhibition: A focused review on recent therapeutic strategies for combating the biofilm mediated infections, Front. Microbiol., 12, 676458, 10.3389/fmicb.2021.676458 · DOI · Paper page
- Swartjes, 2013, A functional DNase I coating to prevent adhesion of bacteria and the formation of biofilm, Adv. Funct. Mater., 23, 2843, 10.1002/adfm.201202927 · DOI · Paper page
- Tahmassebi, 2015, A study of the control of oral plaque biofilms via antibacterial photodynamic therapy, Eur. Arch. Paediatr. Dent., 16, 433, 10.1007/s40368-014-0165-5 · DOI
- Talapko, 2020, The principles, mechanisms, and benefits of unconventional agents in the treatment of biofilm infection, Pharmaceuticals (Basel), 13, 299, 10.3390/ph13100299 · DOI
- Thi, 2020, Pseudomonas aeruginosa biofilms, Int. J. Mol. Sci., 21, 8671, 10.3390/ijms21228671 · DOI · Paper page
- Tovar-Garcia, 2020, Characterization of gallium resistance induced in a Pseudomonas aeruginosa cystic fibrosis isolate, Arch. Microbiol., 202, 617, 10.1007/s00203-019-01777-y · DOI
- Tummler, 2019, Emerging therapies against infections with Pseudomonas aeruginosa, F1000Res, 8, 1371, 10.12688/f1000research.19509.1 · DOI · Paper page
- Tuon, 2022, Pathogenesis of the Pseudomonas aeruginosa biofilm: A review, Pathogens, 11, 300, 10.3390/pathogens11030300 · DOI · Paper page
- Vuotto, 2019, Novel treatment strategies for biofilm-based infections, Drugs, 79, 1635, 10.1007/s40265-019-01184-z · DOI
- Wagner, 2016, Novel strategies for the treatment of Pseudomonas aeruginosa infections, J. Med. Chem., 59, 5929, 10.1021/acs.jmedchem.5b01698 · DOI · Paper page
- Wainwright, 2017, Photoantimicrobials-are we afraid of the light?, Lancet Infect. Dis., 17, e49, 10.1016/s1473-3099(16)30268-7 · DOI · Paper page
- Wang, 2019, Synergistic activity of Fosfomycin, ciprofloxacin, and gentamicin Against Escherichia coli and Pseudomonas aeruginosa biofilms, Front. Microbiol., 10, 2522, 10.3389/fmicb.2019.02522 · DOI
- Wang, 2022, Photocatalytic quantum dot-armed bacteriophage for combating drug-resistant bacterial infection, Adv. Sci. (Weinh), 9, e2105668, 10.1002/advs.202105668 · DOI
- Wang, 2020, Regulation of Pseudomonas aeruginosa biofilms by quorum sensing systems and c-di-GMP, Acta Microbiol. Sin., 61, 1106, 10.13343/j.cnki.wsxb.20200367 · doi:10.13343/j.cnki.wsxb.20200367
- Wang, 2015, The exopolysaccharide Psl-eDNA interaction enables the formation of a biofilm skeleton in Pseudomonas aeruginosa, Environ. Microbiol. Rep., 7, 330, 10.1111/1758-2229.12252 · DOI · Paper page
- Wang, 2021, An engineered bacterium for the targeted delivery of proteins to destroy Pseudomonas aeruginosa biofilms, Acta Microbiol. Sin., 61, 2726, 10.13343/j.cnki.wsxb.20200680 · doi:10.13343/j.cnki.wsxb.20200680
- Wei, 2013, Biofilm matrix and its regulation in Pseudomonas aeruginosa, Int. J. Mol. Sci., 14, 20983, 10.3390/ijms141020983 · DOI · Paper page
- Wen, 2013, Antibacterial and membrane-damaging activities of beta-bungarotoxin B chain, J. Pept. Sci., 19, 1, 10.1002/psc.2463 · doi:10.1002/psc.2463
- Whiteley, 2017, Progress in and promise of bacterial quorum sensing research, Nature, 551, 313, 10.1038/nature24624 · DOI · Paper page
- Wi, 2018, Understanding biofilms and novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections, Infect. Dis. Clin. N. Am., 32, 915, 10.1016/j.idc.2018.06.009 · DOI · Paper page
- Williams, 2019, Towards understanding the molecular basis of nitric oxide-regulated group behaviors in pathogenic bacteria, J. Innate Immun., 11, 205, 10.1159/000494740 · DOI
- Wilton, 2016, Extracellular DNA acidifies biofilms and induces aminoglycoside resistance in Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 60, 544, 10.1128/AAC.01650-15 · DOI · Paper page
- Wu, 2021, Transcriptional profiling of Pseudomonas aeruginosa PAO1 in response to anti-biofilm and anti-infection agent exopolysaccharide EPS273, J. Appl. Microbiol., 130, 265, 10.1111/jam.14764 · DOI
- Xiu, 2021, Recent development of nanomedicine for the treatment of bacterial biofilm infections, Viewpoints, 2, 20200065, 10.1002/VIW.20200065 · DOI
- Yadav, 2021, Recent development in therapeutic strategies targeting Pseudomonas aeruginosa biofilms – a review, Mater. Today Proc., 46, 2359, 10.1016/j.matpr.2021.05.245 · DOI
- Yan, 2014, Bacteriophage polysaccharide depolymerases and biomedical applications, BioDrugs, 28, 265, 10.1007/s40259-013-0081-y · DOI · Paper page
- Yang, 2015, Nitric oxide based strategies for applications of biomedical devices, Biosurf. Biotribol., 1, 177, 10.1016/j.bsbt.2015.08.003 · DOI
- Yong, 2018, The microbial endocrinology of Pseudomonas aeruginosa: inflammatory and immune perspectives, Arch. Immunol. Ther. Exp., 66, 329, 10.1007/s00005-018-0510-1 · DOI
- Yu, 2019, Anti-bacterial activity of mutant chensinin-1 peptide against multidrug-resistant Pseudomonas aeruginosa and its effects on biofilm-associated gene expression, Exp. Ther. Med., 17, 2031, 10.3892/etm.2019.7182 · doi:10.3892/etm.2019.7182
- Yu, 2015, PslG, a self-produced glycosyl hydrolase, triggers biofilm disassembly by disrupting exopolysaccharide matrix, Cell Res., 25, 1352, 10.1038/cr.2015.129 · DOI · Paper page
- Zhang, 2018, Effects of PslG on the surface movement of Pseudomonas aeruginosa, Appl. Environ. Microbiol., 84, e00219-18, 10.1128/AEM.00219-18 · doi:10.1128/aem.00219-18
- Zhao, 2021, Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria, Sci. Transl. Med., 13, eabj0716, 10.1126/scitranslmed.abj0716 · DOI · Paper page
- Zhao, 2018, Extracellular aminopeptidase modulates biofilm development of Pseudomonas aeruginosa by affecting matrix exopolysaccharide and bacterial cell death, Environ. Microbiol. Rep., 10, 583, 10.1111/1758-2229.12682 · DOI
- Zhu, 2022, Slippery liquid-Like solid surfaces with promising antibiofilm performance under both static and flow conditions, ACS Appl. Mater. Interfaces, 14, 6307, 10.1021/acsami.1c14533 · doi:10.1021/acsami.1c14533
- Zhu, 2019, Nitric oxide and iron signaling cues have opposing effects on biofilm development in Pseudomonas aeruginosa, Appl. Environ. Microbiol., 85, e02175-18, 10.1128/AEM.02175-18 · DOI
Cited by
Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
Lorusso, A. B., Carrara, J. A., Barroso, C. D. N., Tuon, F. F., & Faoro, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415779 · Cited by 347
El-Saadony, M. T., Saad, A. M., Mohammed, D. M., Korma, S. A., Alshahrani, M. Y., Ahmed, A. E., Ibrahim, E. H., Salem, H. M., Alkafaas, S. S., Saif, A. M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1491777 · Cited by 197
Acharya, P., Lloyd, C., Lam, N. T., Kumke, J., Ray, S., Yanira Muñoz Ramirez, Z., Das, S., & Lam, H. N. (2026) · mSphere · doi:10.1128/msphere.00870-25 · Cited by 8
Hariyudo, H., Benokri, H. R., Wirohadidjojo, Y. W., Herdini, C., Budiyanto, A., & Nugroho, D. B. (2025) · Journal of Clinical Medicine Research · doi:10.14740/jocmr6312 · Cited by 1
Metadata
- Authors
- Yin, R., Cheng, J., Wang, J., Li, P., & Lin, J.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-08-26
- Volume
- 13
- ISSN
- 1664-302X
- Cited by
- 151
- References
- 14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.